Background: Background. The majority of rectal cancers diagnosed in the US are adenocarcinomas. Rectal squamous cell carcinoma (RSCC) is rare, representing only 1-2% of rectal tumors in the general population. However, we observed in preliminary analyses that ~30% of rectal tumors in HIV-infected persons were RSCC. We therefore explored whether HIV-infected persons have a significantly higher risk of RSCC.
Methods: Methods. We utilized the HIV/AIDS Cancer Match, a linkage of US HIV and cancer registries (1991-2010), to ascertain cases of rectal (squamous and non-squamous) and anal cancer. We calculated standardized incidence ratios (SIRs) comparing the number of observed cases in HIV-infected persons to the number expected based on general population rates. To examine whether RSCC in HIV-infected persons represents systematically misclassified anal cancer rather than a distinct entity, investigators reviewed case notes for a subset of rectal and anal tumors.
Results: Results. Among 1,194 HIV-infected persons, 89 cases of RSCC were diagnosed. HIV-infected persons had an elevated risk of RSCC (SIR=28.9; 95% CI 23.2-35.6), similar to that reported for anal cancer (SIR=32.3; 95% CI 30.0-34.6). The largest RSCC excess occurred in MSM (SIR=61.2; 95% CI 47.8-77.0). In contrast, non-squamous rectal cancer risk was not elevated among HIV-infected persons (SIR=0.88; 95% CI 0.74-1.04). Approximately 33% of RSCC cases were determined to be misclassified anal cancer cases after review, but misclassification was non-differential (HIV-infected: 34.5%; HIV-uninfected: 33.3%).
Conclusions: Conclusions. HIV is associated with a substantial excess risk of RSCC. The pattern of excess risk is similar to that observed for anal cancer, an HPV-associated tumor. Although a portion of cases may be misclassified anal cancer, the amount of misclassification was too small to explain the excess. RSCC in HIV-infected persons could represent a previously unrecognized and etiologically distinct subset of rectal tumors, with the particularly high risk in MSM pointing to involvement of a sexually transmitted infectious agent such as HPV.